Last reviewed · How we verify
Von Willebrand Factor Concentrates
Von Willebrand Factor Concentrates is a Small molecule drug developed by Hoffmann-La Roche. It is currently in Phase 2 development.
At a glance
| Generic name | Von Willebrand Factor Concentrates |
|---|---|
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease (PHASE3)
- An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
- Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
- Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Type 3 Von Willebrand International Registries Inhibitor Prospective Study
- Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
- Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) (NA)
- Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Von Willebrand Factor Concentrates CI brief — competitive landscape report
- Von Willebrand Factor Concentrates updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI
Frequently asked questions about Von Willebrand Factor Concentrates
What is Von Willebrand Factor Concentrates?
Von Willebrand Factor Concentrates is a Small molecule drug developed by Hoffmann-La Roche.
Who makes Von Willebrand Factor Concentrates?
Von Willebrand Factor Concentrates is developed by Hoffmann-La Roche (see full Hoffmann-La Roche pipeline at /company/roche).
What development phase is Von Willebrand Factor Concentrates in?
Von Willebrand Factor Concentrates is in Phase 2.